Article
Genetic alterations in lung cancer: assessing limitations in routine clinical use.
Revista portuguesa de pneumologia - 1 Jan 2000
Macedo Joana Espiga, Costa Angela M S, Barbosa Inês A M, Rebelo Sandra, de Moura Conceição Sotto, da Costa Luís Teixeira, Hespanhol Venceslau
Abstract excerpt
Lung cancer is the most frequent cause of cancer mortality worldwide, responsible for approximately 1.1 million deaths per year. Median survival is short, both as most tumours are diagnosed at an advanced stage and because of the limited efficacy of available treatments. The development of tumour molecular gene- tics carries the promise of altering this state of affairs, as it should lead to a more precise...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
